Usón I, Bes M T, Sheldrick G M, Schneider T R, Hartsch T, Fritz H J
Institut für Anorganische Chemie der Universität, Göttingen, Germany.
Fold Des. 1997;2(6):357-61. doi: 10.1016/S1359-0278(97)00049-7.
Immunoglobulin domains owe a crucial fraction of their conformational stability to an invariant central disulfide bridge, the closure of which requires oxidation. Under the reducing conditions prevailing in cell cytoplasm, accumulation of soluble immunoglobulin is prohibited by its inability to acquire and maintain the native conformation. Previously, we have shown that disulfide-free immunoglobulins can be produced in Escherichia coli and purified from cytoplasmic extracts.
Immunoglobulin REIv is the variable domain of a human kappa light chain. The disulfide-free variant REIv-C23V/Y32H was crystallized and its structure analyzed by X-ray crystallography (2.8 A resolution). The conformation of the variant is nearly identical to that of the wild-type protein and the conformationally stabilized variant REIv-T39K. This constitutes the first crystal structure of an immunoglobulin fragment without a disulfide bridge. The lack of the disulfide bridge produces no obvious local change in structure (compared with the wild type), whereas the Y32H mutation allows the formation of an additional hydrogen bond. There is a further change in the structure that is seen in the dimer in which Tyr49 has flipped out of the dimer interface in the mutant.
Immunoglobulin derivatives without a central disulfide bridge but with stringently conserved wild-type conformation can be constructed in a practical two-step approach. First, the protein is endowed with additional folding stability by the introduction of one or more stabilizing amino acid exchanges; second, the disulfide bridge is destroyed by substitution of one of the two invariant cysteines. Such derivatives can be accumulated in soluble form in the cytoplasmic compartment of the E. coli cell. Higher protein yields and evolutionary refinement of catalytic antibodies by genetic complementation are among the possible advantages.
免疫球蛋白结构域构象稳定性的关键部分归因于一个不变的中央二硫键,该二硫键的形成需要氧化。在细胞质中普遍存在的还原条件下,可溶性免疫球蛋白因无法获得并维持天然构象而无法积累。此前,我们已经证明无二硫键的免疫球蛋白可以在大肠杆菌中产生并从细胞质提取物中纯化。
免疫球蛋白REIv是人κ轻链的可变结构域。无二硫键变体REIv-C23V/Y32H结晶,并通过X射线晶体学分析其结构(分辨率为2.8 Å)。该变体的构象与野生型蛋白以及构象稳定的变体REIv-T39K几乎相同。这是首个无二硫键的免疫球蛋白片段的晶体结构。与野生型相比,无二硫键并未导致明显的局部结构变化,而Y32H突变允许形成一个额外的氢键。在二聚体结构中还存在进一步的变化,即突变体中Tyr49从二聚体界面翻转出来。
可以通过一种实用的两步法构建没有中央二硫键但具有严格保守的野生型构象的免疫球蛋白衍生物。首先,通过引入一个或多个稳定氨基酸替换赋予蛋白质额外的折叠稳定性;其次,通过替换两个不变半胱氨酸之一来破坏二硫键。此类衍生物可以以可溶形式在大肠杆菌细胞的细胞质区室中积累。可能的优势包括更高的蛋白质产量以及通过基因互补对催化抗体进行进化优化。